Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

From being a promising yet underexplored approach in the 1990s, mRNA therapeutics have evolved dramatically. The discovery of ...

Researchers from the Tanenbaum group at the Hubrecht Institute have developed a new microscopy technique to observe how ...

TriLink BioTechnologies, a Maravai LifeSciences (MRVI) company and global provider of life science reagents and services, has signed a ...

The ICMR has initiated the process of development of an ingenious human vaccine candidate against highly-pathogenic avian ...

The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.

Moderna is set to receive $590m in funding from the HHS to expedite the development of mRNA-based pandemic influenza vaccines ...

Moderna, a leader in mRNA vaccine technology ... If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who ...